The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study
- PMID: 15767184
- DOI: 10.1016/j.breast.2004.10.004
The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study
Abstract
Several studies have reported that chemotherapy-treated patients have impaired cognition function relative to control groups. We are conducting a longitudinal study with cognitive assessments at baseline, 6 and 18 months. A planned preliminary analysis of data from 50 chemotherapy patients and 43 healthy controls at baseline and post-treatment found a significant group by time interaction on three measures of verbal and working memory. Chemotherapy patients were more likely to show cognitive decline than controls (OR 2.25). Patients were significantly more likely to have GHQ(12) scores indicative of possible psychological morbidity and showed significant increases in endocrine symptoms and fatigue post-treatment however neither GHQ(12) nor quality-of-life variables were related to cognitive performance.
Similar articles
-
Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.J Clin Oncol. 2003 Nov 15;21(22):4175-83. doi: 10.1200/JCO.2003.01.119. J Clin Oncol. 2003. PMID: 14615445
-
Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.J Clin Oncol. 2005 Nov 1;23(31):8025-32. doi: 10.1200/JCO.2005.01.6550. J Clin Oncol. 2005. PMID: 16258100 Clinical Trial.
-
The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.Cancer. 2004 Jun 1;100(11):2292-9. doi: 10.1002/cncr.20272. Cancer. 2004. PMID: 15160331 Clinical Trial.
-
The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.Brain Cogn. 2005 Oct;59(1):60-70. doi: 10.1016/j.bandc.2005.05.001. Epub 2005 Jun 21. Brain Cogn. 2005. PMID: 15975700 Review.
-
Survivorship and complications of treatment in breast cancer.Clin Adv Hematol Oncol. 2005 Mar;3(3):211-22, 238. Clin Adv Hematol Oncol. 2005. PMID: 16166992 Review.
Cited by
-
Aromatase inhibition abolishes LTP generation in female but not in male mice.J Neurosci. 2012 Jun 13;32(24):8116-26. doi: 10.1523/JNEUROSCI.5319-11.2012. J Neurosci. 2012. PMID: 22699893 Free PMC article.
-
Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.Arch Toxicol. 2022 Jan;96(1):11-78. doi: 10.1007/s00204-021-03171-4. Epub 2021 Nov 2. Arch Toxicol. 2022. PMID: 34725718 Review.
-
Altered intrinsic brain activity after chemotherapy in patients with gastric cancer: A preliminary study.Eur Radiol. 2017 Jul;27(7):2679-2688. doi: 10.1007/s00330-016-4578-x. Epub 2016 Nov 23. Eur Radiol. 2017. PMID: 27878584
-
Candidate mechanisms for chemotherapy-induced cognitive changes.Nat Rev Cancer. 2007 Mar;7(3):192-201. doi: 10.1038/nrc2073. Nat Rev Cancer. 2007. PMID: 17318212 Free PMC article. Review.
-
Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies.Ther Adv Neurol Disord. 2016 Jul;9(4):269-80. doi: 10.1177/1756285616643892. Epub 2016 Apr 18. Ther Adv Neurol Disord. 2016. PMID: 27366233 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical